Cargando…
Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524861/ https://www.ncbi.nlm.nih.gov/pubmed/28674867 http://dx.doi.org/10.1007/s10286-017-0434-6 |
| _version_ | 1783252538280116224 |
|---|---|
| author | Kremens, Daniel Lew, Mark Claassen, Daniel Goodman, Brent P. |
| author_facet | Kremens, Daniel Lew, Mark Claassen, Daniel Goodman, Brent P. |
| author_sort | Kremens, Daniel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5524861 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55248612017-08-08 Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease Kremens, Daniel Lew, Mark Claassen, Daniel Goodman, Brent P. Clin Auton Res Case Vignette Springer Berlin Heidelberg 2017-07-03 2017 /pmc/articles/PMC5524861/ /pubmed/28674867 http://dx.doi.org/10.1007/s10286-017-0434-6 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Case Vignette Kremens, Daniel Lew, Mark Claassen, Daniel Goodman, Brent P. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease |
| title | Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease |
| title_full | Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease |
| title_fullStr | Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease |
| title_full_unstemmed | Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease |
| title_short | Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease |
| title_sort | adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and parkinson disease |
| topic | Case Vignette |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524861/ https://www.ncbi.nlm.nih.gov/pubmed/28674867 http://dx.doi.org/10.1007/s10286-017-0434-6 |
| work_keys_str_mv | AT kremensdaniel addingdroxidopatofludrocortisoneormidodrineinapatientwithneurogenicorthostatichypotensionandparkinsondisease AT lewmark addingdroxidopatofludrocortisoneormidodrineinapatientwithneurogenicorthostatichypotensionandparkinsondisease AT claassendaniel addingdroxidopatofludrocortisoneormidodrineinapatientwithneurogenicorthostatichypotensionandparkinsondisease AT goodmanbrentp addingdroxidopatofludrocortisoneormidodrineinapatientwithneurogenicorthostatichypotensionandparkinsondisease |